Jiang et al. documented that circulating γδ T cells from HCC patients exhibit impaired cytotoxicity compared to healthy controls, a finding attributed to a lower frequency of Vδ2 T cells and reduced IL-2 and IL-21 expression [88]. This evidence concerns the gene IL2 and hepatocellular carcinoma.